nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—DRD4—conduct disorder	0.409	0.485	CbGaD
Aripiprazole—SLC6A4—conduct disorder	0.245	0.291	CbGaD
Aripiprazole—HTR2A—conduct disorder	0.189	0.224	CbGaD
Aripiprazole—HTR7—autonomic nervous system—conduct disorder	0.00367	0.173	CbGeAlD
Aripiprazole—HTR2A—autonomic nervous system—conduct disorder	0.00229	0.108	CbGeAlD
Aripiprazole—Vilazodone—SLC6A4—conduct disorder	0.00196	0.283	CrCbGaD
Aripiprazole—Ziprasidone—DRD4—conduct disorder	0.00124	0.179	CrCbGaD
Aripiprazole—DRD4—brain—conduct disorder	0.00113	0.0532	CbGeAlD
Aripiprazole—HTR1E—brain—conduct disorder	0.000972	0.0459	CbGeAlD
Aripiprazole—CHRM4—brain—conduct disorder	0.000852	0.0403	CbGeAlD
Aripiprazole—DRD3—brain—conduct disorder	0.000792	0.0374	CbGeAlD
Aripiprazole—HTR6—brain—conduct disorder	0.000762	0.036	CbGeAlD
Aripiprazole—Ziprasidone—SLC6A4—conduct disorder	0.000743	0.107	CrCbGaD
Aripiprazole—DRD5—brain—conduct disorder	0.000742	0.0351	CbGeAlD
Aripiprazole—CHRM5—brain—conduct disorder	0.000666	0.0315	CbGeAlD
Aripiprazole—Nefazodone—SLC6A4—conduct disorder	0.000624	0.0902	CrCbGaD
Aripiprazole—ADRA1B—brain—conduct disorder	0.000608	0.0287	CbGeAlD
Aripiprazole—Trazodone—SLC6A4—conduct disorder	0.000578	0.0834	CrCbGaD
Aripiprazole—H1F0—brain—conduct disorder	0.000574	0.0271	CbGeAlD
Aripiprazole—Ziprasidone—HTR2A—conduct disorder	0.000571	0.0825	CrCbGaD
Aripiprazole—DRD1—brain—conduct disorder	0.000567	0.0268	CbGeAlD
Aripiprazole—HTR3A—brain—conduct disorder	0.000548	0.0259	CbGeAlD
Aripiprazole—Nefazodone—HTR2A—conduct disorder	0.00048	0.0693	CrCbGaD
Aripiprazole—HTR1B—brain—conduct disorder	0.00046	0.0217	CbGeAlD
Aripiprazole—CHRM2—brain—conduct disorder	0.000457	0.0216	CbGeAlD
Aripiprazole—HTR1D—brain—conduct disorder	0.000445	0.021	CbGeAlD
Aripiprazole—Trazodone—HTR2A—conduct disorder	0.000444	0.0641	CrCbGaD
Aripiprazole—HTR2C—brain—conduct disorder	0.000441	0.0208	CbGeAlD
Aripiprazole—ADRB1—brain—conduct disorder	0.000432	0.0204	CbGeAlD
Aripiprazole—SLC6A4—brain—conduct disorder	0.000418	0.0197	CbGeAlD
Aripiprazole—CHRM1—brain—conduct disorder	0.000416	0.0197	CbGeAlD
Aripiprazole—HTR2B—brain—conduct disorder	0.000414	0.0196	CbGeAlD
Aripiprazole—CHRM3—brain—conduct disorder	0.000372	0.0176	CbGeAlD
Aripiprazole—HTR1A—brain—conduct disorder	0.000371	0.0175	CbGeAlD
Aripiprazole—HTR7—brain—conduct disorder	0.000354	0.0167	CbGeAlD
Aripiprazole—ADRA1A—brain—conduct disorder	0.000342	0.0162	CbGeAlD
Aripiprazole—DRD2—brain—conduct disorder	0.000335	0.0158	CbGeAlD
Aripiprazole—KCNH2—brain—conduct disorder	0.00033	0.0156	CbGeAlD
Aripiprazole—ADRA2C—brain—conduct disorder	0.000326	0.0154	CbGeAlD
Aripiprazole—Perphenazine—HTR2A—conduct disorder	0.000284	0.0411	CrCbGaD
Aripiprazole—HRH1—brain—conduct disorder	0.000265	0.0125	CbGeAlD
Aripiprazole—ADRA2A—brain—conduct disorder	0.00026	0.0123	CbGeAlD
Aripiprazole—HTR2A—brain—conduct disorder	0.000221	0.0104	CbGeAlD
Aripiprazole—CYP2D6—brain—conduct disorder	0.000201	0.00951	CbGeAlD
Aripiprazole—ABCB1—brain—conduct disorder	0.000145	0.00684	CbGeAlD
Aripiprazole—CHRM4—Signaling by GPCR—DRD4—conduct disorder	4.65e-05	0.00036	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	4.63e-05	0.000359	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	4.61e-05	0.000357	CbGpPWpGaD
Aripiprazole—DRD3—GPCR downstream signaling—DRD4—conduct disorder	4.61e-05	0.000357	CbGpPWpGaD
Aripiprazole—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	4.58e-05	0.000355	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—CGA—conduct disorder	4.58e-05	0.000355	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—DRD4—conduct disorder	4.49e-05	0.000348	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	4.48e-05	0.000348	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CGA—conduct disorder	4.47e-05	0.000347	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—CGA—conduct disorder	4.45e-05	0.000345	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—DRD4—conduct disorder	4.45e-05	0.000345	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	4.41e-05	0.000342	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CGA—conduct disorder	4.41e-05	0.000342	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—DRD4—conduct disorder	4.26e-05	0.00033	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—DRD4—conduct disorder	4.24e-05	0.000328	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	4.2e-05	0.000325	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—DRD4—conduct disorder	4.18e-05	0.000324	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—WASF1—conduct disorder	4.16e-05	0.000323	CbGpPWpGaD
Aripiprazole—DRD5—Signaling by GPCR—HTR2A—conduct disorder	4.16e-05	0.000323	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—WASF1—conduct disorder	4.16e-05	0.000322	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	4.16e-05	0.000322	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—WASF1—conduct disorder	4.13e-05	0.00032	CbGpPWpGaD
Aripiprazole—DRD2—GPCR ligand binding—HTR2A—conduct disorder	4.07e-05	0.000315	CbGpPWpGaD
Aripiprazole—CYP3A4—Biological oxidations—COMT—conduct disorder	4.06e-05	0.000315	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—WASF1—conduct disorder	4.05e-05	0.000313	CbGpPWpGaD
Aripiprazole—CYP3A4—Biological oxidations—MAOA—conduct disorder	4.04e-05	0.000313	CbGpPWpGaD
Aripiprazole—DRD2—Circadian rythm related genes—EP300—conduct disorder	4.03e-05	0.000313	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CGA—conduct disorder	4.02e-05	0.000312	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	4.01e-05	0.000311	CbGpPWpGaD
Aripiprazole—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	4.01e-05	0.000311	CbGpPWpGaD
Aripiprazole—HRH1—GPCR ligand binding—HTR2A—conduct disorder	4e-05	0.00031	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	3.99e-05	0.000309	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CGA—conduct disorder	3.98e-05	0.000309	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	3.98e-05	0.000309	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—WASF1—conduct disorder	3.98e-05	0.000308	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	3.97e-05	0.000308	CbGpPWpGaD
Aripiprazole—CHRM1—Circadian rythm related genes—EP300—conduct disorder	3.95e-05	0.000306	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—CGA—conduct disorder	3.94e-05	0.000305	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	3.93e-05	0.000305	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—WASF1—conduct disorder	3.93e-05	0.000304	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	3.92e-05	0.000304	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	3.88e-05	0.000301	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CGA—conduct disorder	3.85e-05	0.000298	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CGA—conduct disorder	3.83e-05	0.000296	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	3.82e-05	0.000296	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—DRD4—conduct disorder	3.81e-05	0.000295	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—WASF1—conduct disorder	3.8e-05	0.000294	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	3.78e-05	0.000293	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—DRD4—conduct disorder	3.77e-05	0.000292	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—WASF1—conduct disorder	3.76e-05	0.000291	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CGA—conduct disorder	3.72e-05	0.000288	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CGA—conduct disorder	3.66e-05	0.000284	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—DRD4—conduct disorder	3.65e-05	0.000282	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	3.64e-05	0.000282	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—DRD4—conduct disorder	3.63e-05	0.000281	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—CGA—conduct disorder	3.61e-05	0.00028	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—WASF1—conduct disorder	3.58e-05	0.000278	CbGpPWpGaD
Aripiprazole—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	3.54e-05	0.000274	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—WASF1—conduct disorder	3.54e-05	0.000274	CbGpPWpGaD
Aripiprazole—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	3.53e-05	0.000274	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	3.53e-05	0.000273	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—DRD4—conduct disorder	3.52e-05	0.000273	CbGpPWpGaD
Aripiprazole—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	3.51e-05	0.000272	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	3.47e-05	0.000269	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	3.47e-05	0.000269	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—DRD4—conduct disorder	3.46e-05	0.000268	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	3.45e-05	0.000267	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	3.44e-05	0.000266	CbGpPWpGaD
Aripiprazole—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	3.44e-05	0.000266	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	3.4e-05	0.000264	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	3.4e-05	0.000263	CbGpPWpGaD
Aripiprazole—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	3.38e-05	0.000262	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CGA—conduct disorder	3.38e-05	0.000262	CbGpPWpGaD
Aripiprazole—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	3.34e-05	0.000259	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CGA—conduct disorder	3.32e-05	0.000257	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CGA—conduct disorder	3.31e-05	0.000257	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—CGA—conduct disorder	3.31e-05	0.000257	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CGA—conduct disorder	3.3e-05	0.000256	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CGA—conduct disorder	3.29e-05	0.000255	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CGA—conduct disorder	3.26e-05	0.000253	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CGA—conduct disorder	3.25e-05	0.000252	CbGpPWpGaD
Aripiprazole—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	3.23e-05	0.00025	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—WASF1—conduct disorder	3.22e-05	0.00025	CbGpPWpGaD
Aripiprazole—HTR6—Signaling by GPCR—HTR2A—conduct disorder	3.21e-05	0.000249	CbGpPWpGaD
Aripiprazole—HTR7—Signaling by GPCR—HTR2A—conduct disorder	3.21e-05	0.000249	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—DRD4—conduct disorder	3.2e-05	0.000248	CbGpPWpGaD
Aripiprazole—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	3.2e-05	0.000248	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—WASF1—conduct disorder	3.19e-05	0.000247	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	3.19e-05	0.000247	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	3.15e-05	0.000244	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—DRD4—conduct disorder	3.15e-05	0.000244	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—DRD4—conduct disorder	3.14e-05	0.000244	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—DRD4—conduct disorder	3.13e-05	0.000243	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—DRD4—conduct disorder	3.12e-05	0.000242	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	3.12e-05	0.000242	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—DRD4—conduct disorder	3.09e-05	0.00024	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	3.08e-05	0.000239	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—WASF1—conduct disorder	3.08e-05	0.000239	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—HTR2A—conduct disorder	3.07e-05	0.000238	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—WASF1—conduct disorder	3.07e-05	0.000238	CbGpPWpGaD
Aripiprazole—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	3.05e-05	0.000236	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	3.03e-05	0.000235	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CGA—conduct disorder	3.02e-05	0.000234	CbGpPWpGaD
Aripiprazole—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	3.01e-05	0.000233	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—WASF1—conduct disorder	2.98e-05	0.000231	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—WASF1—conduct disorder	2.93e-05	0.000227	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	2.93e-05	0.000227	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—DRD4—conduct disorder	2.91e-05	0.000225	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—DRD4—conduct disorder	2.91e-05	0.000225	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	2.9e-05	0.000225	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—DRD4—conduct disorder	2.89e-05	0.000224	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	2.86e-05	0.000222	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—DRD4—conduct disorder	2.83e-05	0.000219	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—HTR2A—conduct disorder	2.78e-05	0.000215	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—HTR2A—conduct disorder	2.77e-05	0.000214	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—DRD4—conduct disorder	2.74e-05	0.000213	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	2.74e-05	0.000212	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—HTR2A—conduct disorder	2.73e-05	0.000211	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	2.71e-05	0.00021	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—WASF1—conduct disorder	2.71e-05	0.00021	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—WASF1—conduct disorder	2.66e-05	0.000206	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—WASF1—conduct disorder	2.66e-05	0.000206	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—DRD4—conduct disorder	2.66e-05	0.000206	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—WASF1—conduct disorder	2.65e-05	0.000205	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—WASF1—conduct disorder	2.64e-05	0.000205	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—DRD4—conduct disorder	2.63e-05	0.000204	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	2.62e-05	0.000203	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—WASF1—conduct disorder	2.61e-05	0.000203	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—WASF1—conduct disorder	2.61e-05	0.000202	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	2.61e-05	0.000202	CbGpPWpGaD
Aripiprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	2.6e-05	0.000202	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	2.53e-05	0.000196	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—DRD4—conduct disorder	2.5e-05	0.000194	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CGA—conduct disorder	2.5e-05	0.000194	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	2.49e-05	0.000193	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	2.49e-05	0.000193	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—DRD4—conduct disorder	2.47e-05	0.000191	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	2.46e-05	0.000191	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—HTR2A—conduct disorder	2.46e-05	0.000191	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—WASF1—conduct disorder	2.42e-05	0.000188	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	2.38e-05	0.000184	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	2.37e-05	0.000183	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CGA—conduct disorder	2.36e-05	0.000183	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	2.3e-05	0.000178	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	2.3e-05	0.000178	CbGpPWpGaD
Aripiprazole—ADRA2B—Hemostasis—EP300—conduct disorder	2.27e-05	0.000176	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	2.26e-05	0.000176	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	2.26e-05	0.000175	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—DRD4—conduct disorder	2.25e-05	0.000174	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	2.25e-05	0.000174	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	2.24e-05	0.000174	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—DRD4—conduct disorder	2.23e-05	0.000173	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	2.22e-05	0.000172	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.22e-05	0.000172	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.15e-05	0.000167	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.14e-05	0.000166	CbGpPWpGaD
Aripiprazole—ADRA2C—Hemostasis—EP300—conduct disorder	2.12e-05	0.000165	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.09e-05	0.000162	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.08e-05	0.000161	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—COMT—conduct disorder	2.07e-05	0.00016	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.06e-05	0.00016	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—MAOA—conduct disorder	2.05e-05	0.000159	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.05e-05	0.000159	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.05e-05	0.000159	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	2.04e-05	0.000158	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	2.04e-05	0.000158	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	2.02e-05	0.000156	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.01e-05	0.000156	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—COMT—conduct disorder	2.01e-05	0.000156	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—MAOA—conduct disorder	1.99e-05	0.000155	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—HTR2A—conduct disorder	1.9e-05	0.000147	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—HTR2A—conduct disorder	1.9e-05	0.000147	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—DRD4—conduct disorder	1.89e-05	0.000147	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—HTR2A—conduct disorder	1.88e-05	0.000146	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	1.87e-05	0.000145	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—DRD4—conduct disorder	1.86e-05	0.000144	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—DRD4—conduct disorder	1.86e-05	0.000144	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—DRD4—conduct disorder	1.85e-05	0.000143	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—DRD4—conduct disorder	1.84e-05	0.000143	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—HTR2A—conduct disorder	1.84e-05	0.000143	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—DRD4—conduct disorder	1.83e-05	0.000142	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—DRD4—conduct disorder	1.82e-05	0.000141	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—HTR2A—conduct disorder	1.81e-05	0.000141	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—HTR2A—conduct disorder	1.79e-05	0.000139	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—COMT—conduct disorder	1.78e-05	0.000138	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—MAOA—conduct disorder	1.77e-05	0.000137	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—HTR2A—conduct disorder	1.73e-05	0.000134	CbGpPWpGaD
Aripiprazole—ADRA2A—Hemostasis—EP300—conduct disorder	1.73e-05	0.000134	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—HTR2A—conduct disorder	1.71e-05	0.000133	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DRD4—conduct disorder	1.69e-05	0.000131	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—HTR2A—conduct disorder	1.63e-05	0.000127	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—COMT—conduct disorder	1.63e-05	0.000126	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—MAOA—conduct disorder	1.62e-05	0.000126	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—HTR2A—conduct disorder	1.61e-05	0.000125	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CGA—conduct disorder	1.54e-05	0.000119	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—COMT—conduct disorder	1.5e-05	0.000116	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—MAOA—conduct disorder	1.48e-05	0.000115	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—EP300—conduct disorder	1.47e-05	0.000114	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—HTR2A—conduct disorder	1.47e-05	0.000114	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	1.46e-05	0.000113	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.4e-05	0.000109	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.4e-05	0.000108	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.36e-05	0.000105	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.34e-05	0.000104	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—EP300—conduct disorder	1.3e-05	0.000101	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.23e-05	9.56e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.21e-05	9.39e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.21e-05	9.36e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.2e-05	9.33e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.19e-05	9.24e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.19e-05	9.21e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—COMT—conduct disorder	1.13e-05	8.74e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—MAOA—conduct disorder	1.12e-05	8.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.1e-05	8.56e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—COMT—conduct disorder	1.06e-05	8.24e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—MAOA—conduct disorder	1.06e-05	8.18e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—EP300—conduct disorder	1.01e-05	7.79e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—EP300—conduct disorder	1e-05	7.78e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—EP300—conduct disorder	9.98e-06	7.73e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—EP300—conduct disorder	9.77e-06	7.57e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—EP300—conduct disorder	9.62e-06	7.45e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—EP300—conduct disorder	9.49e-06	7.35e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—EP300—conduct disorder	9.18e-06	7.11e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—EP300—conduct disorder	9.08e-06	7.04e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—EP300—conduct disorder	8.87e-06	6.87e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EP300—conduct disorder	8.66e-06	6.71e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—EP300—conduct disorder	8.61e-06	6.68e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EP300—conduct disorder	8.54e-06	6.62e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EP300—conduct disorder	7.78e-06	6.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EP300—conduct disorder	7.71e-06	5.98e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—EP300—conduct disorder	7.62e-06	5.91e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EP300—conduct disorder	7.44e-06	5.77e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EP300—conduct disorder	7.41e-06	5.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EP300—conduct disorder	7.2e-06	5.58e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EP300—conduct disorder	7.09e-06	5.49e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—EP300—conduct disorder	7e-06	5.42e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—COMT—conduct disorder	6.95e-06	5.39e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MAOA—conduct disorder	6.9e-06	5.35e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EP300—conduct disorder	6.54e-06	5.06e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EP300—conduct disorder	6.43e-06	4.98e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EP300—conduct disorder	6.42e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—EP300—conduct disorder	6.41e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EP300—conduct disorder	6.4e-06	4.96e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EP300—conduct disorder	6.38e-06	4.94e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EP300—conduct disorder	6.31e-06	4.89e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EP300—conduct disorder	6.3e-06	4.88e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EP300—conduct disorder	5.85e-06	4.53e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—EP300—conduct disorder	4.84e-06	3.75e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—EP300—conduct disorder	4.56e-06	3.53e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—EP300—conduct disorder	2.98e-06	2.31e-05	CbGpPWpGaD
